Evidence about the Platform-14 Coronary Drug Eluting Balloon | Which Medical Device
Categorised under:
Cardio-thoracic
>
Coronary intervention
>
Drug eluting balloons
Scope of the work: Although the use of drug-eluting stents (DES) has dramatically reduced the incidence of restenosis compared with bare-metal stent (BMS), in-stent restenosis (ISR) using DES is a phenomenon which still exists, and becomes clinically relevant due to the prevalence of complex lesions. The optimal therapeutic strategy of intra-DES ISR remains hotly debated.
Medicated drug eluting balloons (DEB) are a good treatment option, but little data are currently available on medium term follow-up and potential of intra-DES ISR predictors.
Credits: Alessandro S. Bortone Italia DEB- Elutax SV-2013. Presented at JIM 2014.
There are no currently similar devices - Click here to suggest a device
Did you know you can Register for FREE with this website?
Registration gives you full access to all of the features of WhichMedicalDevice. Find out more ...
WhichMedicalDevice is a FREE resource created by clinicians for clinicians.
Registration is free and gives you unlimited access to all of the content and features of this website.
Find out more...Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...
Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.
We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.